To develop techniques and establish a workflow using hyperpolarized carbon‐13 (13C) MRI and the pyruvate‐to‐lactate conversion rate (kPL) biomarker to guide MR‐transrectal ultrasound fusion prostate biopsies. Click to show full abstract
To develop techniques and establish a workflow using hyperpolarized carbon‐13 (13C) MRI and the pyruvate‐to‐lactate conversion rate (kPL) biomarker to guide MR‐transrectal ultrasound fusion prostate biopsies.
               
Click one of the above tabs to view related content.